523 related articles for article (PubMed ID: 32686802)
1. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.
Simó C; García-Cañas V
Food Funct; 2020 Aug; 11(8):6745-6776. PubMed ID: 32686802
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice.
Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM
J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
4. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
[TBL] [Abstract][Full Text] [Related]
5. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
6. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders.
Praveenraj SS; Sonali S; Anand N; Tousif HA; Vichitra C; Kalyan M; Kanna PV; Chandana KA; Shasthara P; Mahalakshmi AM; Yang J; Pandi-Perumal SR; Sakharkar MK; Chidambaram SB
Mol Neurobiol; 2022 Nov; 59(11):6684-6700. PubMed ID: 35986843
[TBL] [Abstract][Full Text] [Related]
7. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
[TBL] [Abstract][Full Text] [Related]
8. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.
Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA
Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200
[TBL] [Abstract][Full Text] [Related]
9. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.
Petriello MC; Hoffman JB; Sunkara M; Wahlang B; Perkins JT; Morris AJ; Hennig B
J Nutr Biochem; 2016 Jul; 33():145-53. PubMed ID: 27155921
[TBL] [Abstract][Full Text] [Related]
10. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
[TBL] [Abstract][Full Text] [Related]
11. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
He M; Tan CP; Xu YJ; Liu Y
Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
[TBL] [Abstract][Full Text] [Related]
14. Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women.
Zhu C; Sawrey-Kubicek L; Bardagjy AS; Houts H; Tang X; Sacchi R; Randolph JM; Steinberg FM; Zivkovic AM
Nutr Res; 2020 Jun; 78():36-41. PubMed ID: 32464420
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.
Cho CE; Taesuwan S; Malysheva OV; Bender E; Tulchinsky NF; Yan J; Sutter JL; Caudill MA
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27377678
[TBL] [Abstract][Full Text] [Related]
16. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
[TBL] [Abstract][Full Text] [Related]
17. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
18. An in vitro exploratory study of dietary strategies based on polyphenol-rich beverages, fruit juices and oils to control trimethylamine production in the colon.
Bresciani L; Dall'Asta M; Favari C; Calani L; Del Rio D; Brighenti F
Food Funct; 2018 Dec; 9(12):6470-6483. PubMed ID: 30465688
[TBL] [Abstract][Full Text] [Related]
19. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
20. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.
Zhou T; Heianza Y; Chen Y; Li X; Sun D; DiDonato JA; Pei X; LeBoff MS; Bray GA; Sacks FM; Qi L
Diabetes Care; 2019 Aug; 42(8):1365-1371. PubMed ID: 31332027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
